171 related articles for article (PubMed ID: 9544263)
1. The human glucagon-like peptide-1 (GLP-1) receptor. Cloning and functional expression.
Dillon JS; Wheeler MB; Leng XH; Ligon BB; Boyd AE
Adv Exp Med Biol; 1997; 426():113-9. PubMed ID: 9544263
[No Abstract] [Full Text] [Related]
2. Point mutations in the first and third intracellular loops of the glucagon-like peptide-1 receptor alter intracellular signaling.
Heller RS; Kieffer TJ; Habener JF
Biochem Biophys Res Commun; 1996 Jun; 223(3):624-32. PubMed ID: 8687446
[TBL] [Abstract][Full Text] [Related]
3. Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2.
Munroe DG; Gupta AK; Kooshesh F; Vyas TB; Rizkalla G; Wang H; Demchyshyn L; Yang ZJ; Kamboj RK; Chen H; McCallum K; Sumner-Smith M; Drucker DJ; Crivici A
Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1569-73. PubMed ID: 9990065
[TBL] [Abstract][Full Text] [Related]
4. Localization of the domains involved in ligand binding and activation of the glucose-dependent insulinotropic polypeptide receptor.
Gelling RW; Wheeler MB; Xue J; Gyomorey S; Nian C; Pederson RA; McIntosh CH
Endocrinology; 1997 Jun; 138(6):2640-3. PubMed ID: 9165060
[TBL] [Abstract][Full Text] [Related]
5. GLP-1 action in L6 myotubes is via a receptor different from the pancreatic GLP-1 receptor.
Yang H; Egan JM; Wang Y; Moyes CD; Roth J; Montrose MH; Montrose-Rafizadeh C
Am J Physiol; 1998 Sep; 275(3):C675-83. PubMed ID: 9730951
[TBL] [Abstract][Full Text] [Related]
6. The glucagon-like peptides: a double-edged therapeutic sword?
Perry T; Greig NH
Trends Pharmacol Sci; 2003 Jul; 24(7):377-83. PubMed ID: 12871671
[No Abstract] [Full Text] [Related]
7. Stimulation of cloned human glucagon-like peptide 1 receptor expressed in HEK 293 cells induces cAMP-dependent activation of calcium-induced calcium release.
Gromada J; Rorsman P; Dissing S; Wulff BS
FEBS Lett; 1995 Oct; 373(2):182-6. PubMed ID: 7589461
[TBL] [Abstract][Full Text] [Related]
8. Identification of glucagon-like peptide-2 (GLP-2)-activated signaling pathways in baby hamster kidney fibroblasts expressing the rat GLP-2 receptor.
Yusta B; Somwar R; Wang F; Munroe D; Grinstein S; Klip A; Drucker DJ
J Biol Chem; 1999 Oct; 274(43):30459-67. PubMed ID: 10521425
[TBL] [Abstract][Full Text] [Related]
9. Exchange of W39 by A within the N-terminal extracellular domain of the GLP-1 receptor results in a loss of receptor function.
Van Eyll B; Göke B; Wilmen A; Göke R
Peptides; 1996; 17(4):565-70. PubMed ID: 8804062
[TBL] [Abstract][Full Text] [Related]
10. The multifaceted potential of glucagon-like peptide-1 as a therapeutic agent.
Lam NT; Kieffer TJ
Minerva Endocrinol; 2002 Jun; 27(2):79-93. PubMed ID: 11961501
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide-1: the basis of a new class of treatment for type 2 diabetes.
Knudsen LB
J Med Chem; 2004 Aug; 47(17):4128-34. PubMed ID: 15293981
[No Abstract] [Full Text] [Related]
12. A novel neurotrophic property of glucagon-like peptide 1: a promoter of nerve growth factor-mediated differentiation in PC12 cells.
Perry T; Lahiri DK; Chen D; Zhou J; Shaw KT; Egan JM; Greig NH
J Pharmacol Exp Ther; 2002 Mar; 300(3):958-66. PubMed ID: 11861804
[TBL] [Abstract][Full Text] [Related]
13. Functional studies of a glucagon receptor isolated from frog Rana tigrina rugulosa: implications on the molecular evolution of glucagon receptors in vertebrates.
Ngan ES; Chow LS; Tse DL; Du X; Wei Y; Mojsov S; Chow BK
FEBS Lett; 1999 Sep; 457(3):499-504. PubMed ID: 10471837
[TBL] [Abstract][Full Text] [Related]
14. Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells.
Salapatek AM; MacDonald PE; Gaisano HY; Wheeler MB
Mol Endocrinol; 1999 Aug; 13(8):1305-17. PubMed ID: 10446905
[TBL] [Abstract][Full Text] [Related]
15. Molecular cloning, functional expression, and signal transduction of the GIP-receptor cloned from a human insulinoma.
Volz A; Göke R; Lankat-Buttgereit B; Fehmann HC; Bode HP; Göke B
FEBS Lett; 1995 Oct; 373(1):23-9. PubMed ID: 7589426
[TBL] [Abstract][Full Text] [Related]
16. Glucagon-like peptide-1: regulation of insulin secretion and therapeutic potential.
Gromada J; Brock B; Schmitz O; Rorsman P
Basic Clin Pharmacol Toxicol; 2004 Dec; 95(6):252-62. PubMed ID: 15569269
[TBL] [Abstract][Full Text] [Related]
17. Desensitization and phosphorylation of the glucagon-like peptide-1 (GLP-1) receptor by GLP-1 and 4-phorbol 12-myristate 13-acetate.
Widmann C; Dolci W; Thorens B
Mol Endocrinol; 1996 Jan; 10(1):62-75. PubMed ID: 8838146
[TBL] [Abstract][Full Text] [Related]
18. Signal transduction of the GLP-1-receptor cloned from a human insulinoma.
van Eyll B; Lankat-Buttgereit B; Bode HP; Göke R; Göke B
FEBS Lett; 1994 Jul; 348(1):7-13. PubMed ID: 7517895
[TBL] [Abstract][Full Text] [Related]
19. Metabolic stability, receptor binding, cAMP generation, insulin secretion and antihyperglycaemic activity of novel N-terminal Glu9-substituted analogues of glucagon-like peptide-1.
Green BD; Gault VA; Irwin N; Mooney MH; Bailey CJ; Harriott P; Greer B; Flatt PR; O'Harte FP
Biol Chem; 2003 Dec; 384(12):1543-51. PubMed ID: 14719796
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity studies of glucagon-like peptide-1.
Adelhorst K; Hedegaard BB; Knudsen LB; Kirk O
J Biol Chem; 1994 Mar; 269(9):6275-8. PubMed ID: 8119974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
